170 related articles for article (PubMed ID: 36939172)
1. Optimization of magnetic nanoparticles for engineering erythrocytes as theranostic agents.
Slavu LM; Antonelli A; Scarpa ES; Abdalla P; Wilhelm C; Silvestri N; Pellegrino T; Scheffler K; Magnani M; Rinaldi R; Di Corato R
Biomater Sci; 2023 May; 11(9):3252-3268. PubMed ID: 36939172
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
Kandasamy G; Maity D
Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
[TBL] [Abstract][Full Text] [Related]
3. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
[TBL] [Abstract][Full Text] [Related]
4. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
Zhu L; Zhou Z; Mao H; Yang L
Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
[TBL] [Abstract][Full Text] [Related]
5. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
6. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
7. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
8. Unveiling the role of surface, size, shape and defects of iron oxide nanoparticles for theranostic applications.
Cotin G; Blanco-Andujar C; Perton F; Asín L; de la Fuente JM; Reichardt W; Schaffner D; Ngyen DV; Mertz D; Kiefer C; Meyer F; Spassov S; Ersen O; Chatzidakis M; Botton GA; Hénoumont C; Laurent S; Greneche JM; Teran FJ; Ortega D; Felder-Flesch D; Begin-Colin S
Nanoscale; 2021 Sep; 13(34):14552-14571. PubMed ID: 34473175
[TBL] [Abstract][Full Text] [Related]
9. RBC micromotors carrying multiple cargos towards potential theranostic applications.
Wu Z; Esteban-Fernández de Ávila B; Martín A; Christianson C; Gao W; Thamphiwatana SK; Escarpa A; He Q; Zhang L; Wang J
Nanoscale; 2015 Aug; 7(32):13680-6. PubMed ID: 26214151
[TBL] [Abstract][Full Text] [Related]
10. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
Amiri M; Salavati-Niasari M; Akbari A
Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
[TBL] [Abstract][Full Text] [Related]
11. Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia.
Das P; Salvioni L; Malatesta M; Vurro F; Mannucci S; Gerosa M; Antonietta Rizzuto M; Tullio C; Degrassi A; Colombo M; Ferretti AM; Ponti A; Calderan L; Prosperi D
J Colloid Interface Sci; 2020 Nov; 579():186-194. PubMed ID: 32590159
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Functionalization, and Design of Magnetic Nanoparticles for Theranostic Applications.
Mosayebi J; Kiyasatfar M; Laurent S
Adv Healthc Mater; 2017 Dec; 6(23):. PubMed ID: 28990364
[TBL] [Abstract][Full Text] [Related]
13. Engineered Theranostic Magnetic Nanostructures: Role of Composition and Surface Coating on Magnetic Resonance Imaging Contrast and Thermal Activation.
Nandwana V; Ryoo SR; Kanthala S; De M; Chou SS; Prasad PV; Dravid VP
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6953-61. PubMed ID: 26936392
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Nanoparticles: Current Trends and Future Aspects in Diagnostics and Nanomedicine.
Vallabani NVS; Singh S; Karakoti AS
Curr Drug Metab; 2019; 20(6):457-472. PubMed ID: 30465498
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of modified magnetic nanoparticles as theranostic agents: in vitro safety assessment in healthy cells.
Prokopiou E D; Pissas M; Fibbi G; Margheri F; Kalska-Szostko B; Papanastasiou G; Jansen M; Wang J; Laurenzana A; Efthimiadou K E
Toxicol In Vitro; 2021 Apr; 72():105094. PubMed ID: 33460736
[TBL] [Abstract][Full Text] [Related]
17. High-Performance Worm-like Mn-Zn Ferrite Theranostic Nanoagents and the Application on Tumor Theranostics.
Sun Y; Yan C; Xie J; Yan D; Hu K; Huang S; Liu J; Zhang Y; Gu N; Xiong F
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29536-29548. PubMed ID: 31333014
[TBL] [Abstract][Full Text] [Related]
18. Galactomannan armed superparamagnetic iron oxide nanoparticles as a folate receptor targeted multi-functional theranostic agent in the management of cancer.
R S; M Joseph M; Sen A; K RP; Bs U; Tt S
Int J Biol Macromol; 2022 Oct; 219():740-753. PubMed ID: 35907463
[TBL] [Abstract][Full Text] [Related]
19. New strategies to prolong the in vivo life span of iron-based contrast agents for MRI.
Antonelli A; Sfara C; Battistelli S; Canonico B; Arcangeletti M; Manuali E; Salamida S; Papa S; Magnani M
PLoS One; 2013; 8(10):e78542. PubMed ID: 24223101
[TBL] [Abstract][Full Text] [Related]
20. Targeted superparamagnetic iron oxide nanoparticles for early detection of cancer: Possibilities and challenges.
Bakhtiary Z; Saei AA; Hajipour MJ; Raoufi M; Vermesh O; Mahmoudi M
Nanomedicine; 2016 Feb; 12(2):287-307. PubMed ID: 26707817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
